Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_assertion type Assertion NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_head.
- NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_assertion description "[GSTT1 null genotype was associated with 2.23-fold (p < 0.05) increased risk for HCC development as compared to the control group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_provenance.
- NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_assertion evidence source_evidence_literature NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_provenance.
- NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_assertion SIO_000772 18816171 NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_provenance.
- NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_assertion wasDerivedFrom befree-2016 NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_provenance.
- NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_assertion wasGeneratedBy ECO_0000203 NP694906.RAE9D43aN5QkXaLqjNDWpc3x-Qc4qMdAgssgvr-ANhDRY130_provenance.